| http://www.w3.org/ns/prov#value | - The European Association of Urology???s guidelines on ???Muscle-invasive and metastatic bladder cancer??? (Witjes et al, 2013) stated that ???Zoledronic acid and denosumab have been approved for all cancer types including urothelial cancer, because they reduce and delay skeletal-related events in metastatic bone disease???.
|
